arrow_back Trending Legislation
Share share

Protecting Biological IP: New Export Rules for Synthetic DNA/RNA.

This act establishes new rules for exporting digital sequences of synthetic DNA and RNA. Its purpose is to safeguard U.S. intellectual property and sensitive information in synthetic biology from exploitation by certain foreign entities. This aims to prevent innovation theft and protect the national security of the United States.
Key points
Requires a license for exporting digital sequences of synthetic DNA and RNA to specific foreign entities of concern.
Aims to protect U.S. innovation in synthetic biology from theft and misuse by foreign adversaries.
Primarily impacts companies and researchers working with advanced biological technologies, affecting their international collaborations.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Introduced
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Biological Intellectual Property Protection Act of 2025
Print number: HR 6624
Sponsor: Rep. Davidson, Warren [R-OH-8]
Process start date: 2025-12-11
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Protecting Biological IP: New Export Rules for Synthetic DNA/RNA.

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HR 6624.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-12-11.

What are the main provisions?

Key points include:

  • Requires a license for exporting digital sequences of synthetic DNA and RNA to specific foreign entities of concern.
  • Aims to protect U.S. innovation in synthetic biology from theft and misuse by foreign adversaries.
  • Primarily impacts companies and researchers working with advanced biological technologies, affecting their international collaborations.

What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Davidson, Warren [R-OH-8].

What is the latest detailed status?

The latest detailed status is: Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 30 - 14.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2026-01-11.

Analysis and Potential Impact of HR 6624

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Security Economy